Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds.
from Gadgets Now https://ift.tt/3c6t2Hs
No comments:
Post a Comment